|
LOC646471 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.653200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.938970E-01 |
| Normal-vs-Stage2 |
1.975350E-01 |
| Normal-vs-Stage3 |
6.752800E-01 |
| Normal-vs-Stage4 |
1.130000E-01 |
| Stage1-vs-Stage2 |
5.343200E-01 |
| Stage1-vs-Stage3 |
1.075610E-01 |
| Stage1-vs-Stage4 |
3.716300E-03 |
| Stage2-vs-Stage3 |
1.311970E-01 |
| Stage2-vs-Stage4 |
2.707600E-02 |
| Stage3-vs-Stage4 |
2.684200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.198000E-01 |
| Normal-vs-AfricanAmerican |
1.588020E-01 |
| Normal-vs-Asian |
1.024580E-01 |
| Caucasian-vs-AfricanAmerican |
1.818400E-01 |
| Caucasian-vs-Asian |
4.770100E-02 |
| AfricanAmerican-vs-Asian |
1.562000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.410600E-01 |
| Normal-vs-Female |
2.082000E-01 |
| Male-vs-Female |
1.790790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.771400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.473370E-01 |
| Normal-vs-Age(61-80Yrs) |
6.455400E-01 |
| Normal-vs-Age(81-100Yrs) |
5.667400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.063600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.605000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.797800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.460300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.482200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.854000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.934000E-02 |
| Normal-vs-Grade 2 |
2.439400E-01 |
| Normal-vs-Grade 3 |
6.706400E-01 |
| Normal-vs-Grade 4 |
1.214180E-02 |
| Grade 1-vs-Grade 2 |
4.911600E-02 |
| Grade 1-vs-Grade 3 |
1.180190E-01 |
| Grade 1-vs-Grade 4 |
2.597700E-02 |
| Grade 2-vs-Grade 3 |
4.271800E-01 |
| Grade 2-vs-Grade 4 |
2.610500E-04 |
| Grade 3-vs-Grade 4 |
2.423700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.745830E-01 |
| Normal-vs-ccB subtype |
8.996000E-01 |
| ccA subtype-vs-ccB subtype |
2.394200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.996200E-01 |
| Normal-vs-N1 |
1.188640E-01 |
| N0-vs-N1 |
1.709960E-01 |
|
|
